Jigna Pharmaceuticals is a company registered in 2022 in Navi Mumbai, Maharashtra, India, with a mission to supply high-quality pharmaceutical products as a trusted trader and supplier. Our portfolio includes products like dermatological preparations, antifungal drugs, pain management formulations, cardiovascular medicines, and health supplements. All these are developed to cater to the efficiency and safety specifications through the manufacturing of clindamycin phosphate and adapalene gel, luliconazole, diclofenac virgin linseed oil methyl salicylate, and menthol gel, aceclofenac and paracetamol tablets, amlodipine tablets, vitamin D3 syrup, and itraconazole capsules BP. Quality commitment is realized through compliance with international pharmaceutical regulations, research and development of the latest medicines, and concern for patient safety.
Key Facts of Jigna Pharmaceuticals:
Nature
of Business
|
Trader,
Supplier
|
Location
|
Navi
Mumbai, Maharashtra, India
|
Year
of Establishment
|
2022
|
Number
of Employees
|
10
|
GST
Number
|
27FYTPP4292K1ZC
|
Bankers
|
Karnataka
Bank
|
Annual
Turnover
|
INR
25 Crore
|
Modes
of Transport
|
By
Road
|
Modes
of Payment
|
Online
Payments (NEFT/RTGS/IMPS), Checque/DD, Cash
|
|
|
|
|